Theralink
About
News & Media
Biopharmas
Investor Relations
Contacts

Head Engineering

Theralink → Head Engineering

Senior Рathologist

Matthew Atkins

Theralink Technologies intends to be a market leader in precision medicine for more effective cancer treatments

Menu

About
Investors
Contact
Privacy Policy

OUR SERVICES

Biopharmas
Oncologists
Media Room

Press Releases

Theralink® Technologies Expands Adoption of its Precision Medicine Technology in the Biopharmaceutical Industry
Avera Health and Theralink® Technologies Announce Strategic Collaboration to Accelerate Adoption of Precision Oncology and Personalized Cancer Care
Theralink® Technologies Announces New PLA Code and Information Submittal to Medicare Contractors for the Theralink Assay for Advanced Breast Cancer Patients

Copyright © 2022 Theralink. All rights reserved.